Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Operating Expenses (2020 - 2024)

RAPT Therapeutics' Operating Expenses history spans 5 years, with the latest figure at $54.5 million for Q4 2024.

  • For Q4 2024, Operating Expenses rose 63.97% year-over-year to $54.5 million; the TTM value through Dec 2024 reached $136.1 million, up 7.11%, while the annual FY2024 figure was $136.1 million, 7.11% up from the prior year.
  • Operating Expenses for Q4 2024 was $54.5 million at RAPT Therapeutics, up from $19.8 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $54.5 million in Q4 2024 and bottomed at $13.8 million in Q2 2020.
  • The 5-year median for Operating Expenses is $20.6 million (2022), against an average of $24.1 million.
  • The largest YoY upside for Operating Expenses was 63.97% in 2024 against a maximum downside of 41.66% in 2024.
  • A 5-year view of Operating Expenses shows it stood at $14.4 million in 2020, then skyrocketed by 30.6% to $18.8 million in 2021, then surged by 30.02% to $24.4 million in 2022, then soared by 35.96% to $33.2 million in 2023, then soared by 63.97% to $54.5 million in 2024.
  • Per Business Quant, the three most recent readings for RAPT's Operating Expenses are $54.5 million (Q4 2024), $19.8 million (Q3 2024), and $29.3 million (Q2 2024).